Skip to main content
OpenTrials
Completed

NCT Number: NCT03120026

Improving Rehabilitation In Sarcopenia (IRIS)

This randomized, double-blind, placebo-controlled supplementation trial tested the hypothesis that nutritional supplementation with muscle-target nutritional supplementation concurrent with regular, controlled physical activity would increase the efficacy of physical rehabilitation in old adults suffering from sarcopenia

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Geriatric physical medicine and rehabilitation division at the Istituto Santa Margherita - Azienda di Servizi alla Persona di Pavia, Pavia, Italy

Loading trial locations.

About this study

This randomized, double-blind, placebo-controlled supplementation trial tested the hypothesis that nutritional supplementation with whey protein, essential amino acids - mainly leucine - vitamin D and calcium concurrent with regular, controlled physical activity would increase the efficacy of physical rehabilitation in old adults suffering from sarcopenia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 65 years or older
  • admission for physical rehabilitation
  • sarcopenia, measured with bioelectrical impedance assessment (BIA) + handgrip strength and gait speed
  • Mini Mental State Examination ≥18
  • Informed consent

Exclusion criteria

  • Any malignant disease during the last five years
  • Known kidney failure (previous glomerular filtration rate <30 ml/min);
  • Known liver failure (Child B or C)
  • Psychiatric disease
  • Endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis)
  • Indications related to the study product:

More than 10 µg (400 IU) of daily Vitamin D intake from medical sources More than 500 mg of daily calcium intake from medical sources. Adherence to a high energy or high protein diet up or use of protein containing or amino acid containing nutritional supplements up to three months before starting the study.

  • Known allergy to milk, milk products or other components of the proposed interventions
  • Indication to or ongoing artificial nutrition support
  • Inclusion in other nutrition intervention trials
  • Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements
  • Refusal

Treatment and study plan

Experimental product

Dietary Supplement

Two servings (40 grams each) of powder (Fortifit; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.

Isocaloric placebo

Dietary Supplement

Two servings (40 grams each) of an isocaloric (maltodextrins) powder which has to be dissolved in 125 ml of water.

Primary outcomes

  1. Gait speed

    Time frame: 8 weeks

    Change in gait speed (4-meter walking test)/month

Secondary outcomes

  1. Physical performance - Tinetti

    Time frame: 8 weeks

    Change in Tinetti scale

  2. Physical performance - Timed Up and Go test

    Time frame: 8 weeks

    Change in timed up and go test

  3. Physical performance - chair-stand

    Time frame: 8 weeks

    chair-stand test

  4. Functional status - Barthel

    Time frame: 8 weeks

    Change in Barthel index score

  5. Functional status - ADL

    Time frame: 8 weeks

    Change in activities of daily living (ADL) score

  6. Functional status - handgrip strength

    Time frame: 8 weeks

    Change in handgrip strength

  7. Body weight

    Time frame: 8 weeks

    Change in body weight

  8. Muscle mass

    Time frame: 8 weeks

    Change in appendicular muscle mass

  9. Cognitive function - trail making test

    Time frame: 8 weeks

    Change in trail making test

  10. Cognitive function - Mini Mental State Examination

    Time frame: 8 weeks

    Change in Mini Mental State Examination

  11. Quality of life

    Time frame: 8 weeks

    Change in 12-item Short-Form Health Survey score (physical/mental components)

  12. Costs

    Time frame: 8 weeks

    Difference in costs of care (using lenght of stay and duration of rehabilitation as surrogate measures)

  13. Adverse events

    Time frame: 8 weeks

    Difference in rate of adverse events related to gastrointestinal intolerance

Other outcomes

  1. Intensity of care

    Time frame: 8 weeks

    Reduction in the level of intensity of care on a ordinal scale

  2. Type of discharge

    Time frame: 8 weeks

    Proportion of patients discharged at home

Sponsors and collaborators

Lead sponsor

Azienda di Servizi alla Persona di Pavia

Other

Registry information

Official study title

A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Sarcopenia in Older Adults Undergoing Physical Rehabilitation the IRIS (Improving Rehabilitation In Sarcopenia) Study: a Randomized, Double-blind, Placebo-controlled Trial.

Acronym: IRIS

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Apr 19, 2017
Registry last updated
Jan 31, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.